{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:31:50Z","timestamp":1777645910362,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-89378"],"award-info":[{"award-number":["MOP-89378"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.antiviral.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T07:45:52Z","timestamp":1442216752000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone"],"prefix":"10.1016","volume":"123","author":[{"given":"Coraline","family":"Canivet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafik","family":"Menasria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Rh\u00e9aume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Piret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.09.007_b0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcv.2006.09.006","article-title":"Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis","volume":"37","author":"Boivin","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0010","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1099\/vir.0.041046-0","article-title":"Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis","volume":"93","author":"Boivin","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.antiviral.2012.09.022","article-title":"Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis","volume":"96","author":"Boivin","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.09.007_b0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.antiviral.2013.10.007","article-title":"The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis","volume":"100","author":"Boivin","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.09.007_b0025","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.167.5.2902","article-title":"Bystander activation involving T lymphocytes in herpetic stromal keratitis","volume":"167","author":"Deshpande","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","article-title":"Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses","volume":"80","author":"Efferth","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.antiviral.2015.09.007_b0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/095632029500600402","article-title":"The effects of delayed-onset chemotherapy using famciclovir or valaciclovir in a murine immunosuppression model for HSV-1","volume":"6","author":"Field","year":"1995","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2015.09.007_b0040","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00519-12","article-title":"Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication","volume":"56","author":"He","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.09.007_b0045","doi-asserted-by":"crossref","first-page":"pe25","DOI":"10.1126\/scisignal.267pe25","article-title":"Immune regulation by rapamycin: moving beyond T cells","volume":"2","author":"Janes","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.antiviral.2015.09.007_b0050","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2003-08-2674","article-title":"Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9","volume":"103","author":"Krug","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2015.09.007_b0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.0308057100","article-title":"Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis","volume":"101","author":"Kurt-Jones","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2015.09.007_b0060","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1128\/JVI.00295-12","article-title":"Herpes simplex virus glycoproteins gH\/gL and gB bind toll-like receptor 2, and soluble gH\/gL is sufficient to activate NF-kappaB","volume":"86","author":"Leoni","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.intimp.2007.10.024","article-title":"Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation","volume":"8","author":"Li","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.intimp.2009.12.006","article-title":"Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation","volume":"10","author":"Li","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0075","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.181.9.6417","article-title":"Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis","volume":"181","author":"Marques","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/rmv.716","article-title":"Sensing herpes: more than toll","volume":"22","author":"Melchjorsen","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0085","first-page":"349","article-title":"Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. Current drug targets","volume":"2","author":"Pong","year":"2003","journal-title":"CNS Neurol. Disorders"},{"key":"10.1016\/j.antiviral.2015.09.007_b0090","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4049\/jimmunol.162.5.2775","article-title":"Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation","volume":"162","author":"Powell","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3851\/IMP2683","article-title":"A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?","volume":"19","author":"Ramos-Estebanez","year":"2014","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2015.09.007_b0100","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI60893","article-title":"TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice","volume":"122","author":"Reinert","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2015.09.007_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/187152611795768088","article-title":"Herpes simplex encephalitis: from virus to therapy","volume":"11","author":"Rozenberg","year":"2011","journal-title":"Infect. Disorders Drug Targets"},{"key":"10.1016\/j.antiviral.2015.09.007_b0110","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bmt.2012.46","article-title":"Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT","volume":"47","author":"Sellar","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2015.09.007_b0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/511987","article-title":"Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice","volume":"195","author":"Sergerie","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.09.007_b0120","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.4049\/jimmunol.181.12.8604","article-title":"TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain","volume":"181","author":"Sorensen","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0125","series-title":"Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard","author":"Swierkosz","year":"2004"},{"key":"10.1016\/j.antiviral.2015.09.007_b0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0135","first-page":"169","article-title":"Update on herpes simplex encephalitis","volume":"1","author":"Tyler","year":"2004","journal-title":"Rev. Neurol. Dis."},{"key":"10.1016\/j.antiviral.2015.09.007_b0140","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/JVI.06010-11","article-title":"Role of specific innate immune responses in herpes simplex virus infection of the central nervous system","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0145","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","article-title":"Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses","volume":"80","author":"Weber","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.007_b0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2015.09.007_b0155","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood-2010-09-310888","article-title":"Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells","volume":"117","author":"Weichhart","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2015.09.007_b0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/09273948.2012.709575","article-title":"Topical use of rapamycin in herpetic stromal keratitis","volume":"20","author":"Zapata","year":"2012","journal-title":"Ocular Immunol. Inflammation"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T01:48:55Z","timestamp":1691977735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":32,"alternative-id":["S0166354215002181"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}